Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8238532 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
The maximal tolerated dose in this study was 47.5 Gy. The high rates of pathologic response of Grade 3+ and 4 must be confirmed through the accrual of new patients in the Phase II study.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
José Javier M.D., Leire M.D., Javier M.D., José Luis M.D., Jesús Javier M.D., Marta M.D., Juan Diego M.Sc., Juan Antonio M.D., Jesús Miguel M.D., Rafael M.D.,